Drug Discovery

Why Is Johnson & Johnson Facing a $966M Talc Verdict?
Research & Development Why Is Johnson & Johnson Facing a $966M Talc Verdict?

In a stunning turn of events that has captured national attention, a Los Angeles jury recently ordered Johnson & Johnson, a multinational giant in the healthcare industry, to pay a staggering $966 million to the family of Mae Moore, a California resident who tragically passed away in 2021 from

Roche's Giredestrant Delays Breast Cancer Progression
Research & Development Roche's Giredestrant Delays Breast Cancer Progression

Today, we’re thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies in the pharmaceutical industry. With his deep understanding of cutting-edge treatments, Ivan is the perfect

DNA-Based Drug Sensor – Review
Research & Development DNA-Based Drug Sensor – Review

In the realm of modern healthcare, ensuring the right drug dosage for each patient remains a formidable challenge, with studies revealing that up to 50% of patients on critical therapies like chemotherapy receive suboptimal doses due to individual variations in drug metabolism. This discrepancy

Can a New Vaccine Stop H. Pylori and Stomach Ulcers?
Research & Development Can a New Vaccine Stop H. Pylori and Stomach Ulcers?

I'm thrilled to sit down with Ivan Kairatov, a renowned biopharma expert with a wealth of experience in research and development, particularly in the realm of innovative technologies shaping the industry. Today, we’re diving into the groundbreaking work surrounding vaccine development for

How Effective Are Novel SARS-CoV-2 Vaccines Against Infection?
Research & Development How Effective Are Novel SARS-CoV-2 Vaccines Against Infection?

The COVID-19 pandemic, triggered by the SARS-CoV-2 virus, has left an indelible mark on the world since its emergence in late 2019, claiming millions of lives and disrupting economies and daily routines on a global scale. This unprecedented crisis spurred an urgent race among scientists to develop

Can Kailera's $600M Funding Redefine Obesity Treatment?
Research & Development Can Kailera's $600M Funding Redefine Obesity Treatment?

Short introductionToday, we’re thrilled to sit down with Ivan Kairatov, a seasoned biopharma expert with extensive experience in research, development, and innovation within the industry. With a keen eye on the evolving landscape of obesity treatments, Ivan offers unique insights into the

Loading

Subscribe to our weekly news digest.

Join now and become a part of our fast-growing community.

Invalid Email Address
Thanks for Subscribing!
We'll be sending you our best soon!
Something went wrong, please try again later